Bankrupt K-V Fights Hologic Bid To Reacquire Makena Rights

Law360, New York (September 24, 2012, 4:20 PM EDT) -- Ailing drugmaker K-V Pharmaceutical Co. on Thursday told a New York federal judge that creditor Hologic Inc. is trying to skirt bankruptcy law by seeking worldwide rights to Makena, a drug that prevents premature birth, and is wrongly suggesting the potential blockbuster medicine is rapidly losing value.

K-V’s objections, filed seven weeks after the St. Louis-based company sought Chapter 11 protection, are an attempt to keep in place a court order that for now shields from creditors the company’s assets, including Makena, a hormone therapy some...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.